ArticleClinics in dermatology
Global impact on dermatology practice due to the COVID-19 pandemic.
Article in Clinics in dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- The Epidemiology of Malignant Melanoma during the First Two Years of the COVID-19 Pandemic: A Systematic Review.International journal of environmental research and public health · 2022Pooled it
- Transition from In-Person to Online Boards-An Exploratory Pilot Study on Pituitary Tumor Board Meetings.Journal of clinical medicine · 2026Article
- Insights into the morbidity profiles of epidemiologically excluded COVID-19 patients in primary care settings during the third wave of the pandemic in the Anuradhapura District, Sri Lanka.BMC primary care · 2025Article
- Wait times for surgery of cutaneous malignancies following the COVID-19 pandemic: a retrospective cohort analysis.Archives of dermatological research · 2024Article
- Article
- A Cross-Sectional Study on Factors Affecting the Decision to Conduct Dermatologic Surgery Procedures During the COVID-19 Pandemic.Dermatology and therapy · 2022Article
- Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review.Journal of cosmetic dermatology · 2022Review
- Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona.International journal of environmental research and public health · 2021Observational
- Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19.International journal of women's dermatology · 2021Review
- Impact of COVID-19 pandemic on dermatology practices: Results of a web-based, global survey.International journal of women's dermatology · 2021Article
- Availability of personal protective equipment among dermatologists in the COVID-19 pandemic: Assessment and risk factors in a web-based, global study.Clinics in dermatologyArticle
- Virtual conferences and e-learning in dermatology during COVID-19 pandemic: Results of a web-based, global survey.Clinics in dermatologyArticle
- Commentary: COVID-19 pandemic - 1 Year later.Clinics in dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This contribution focuses on the effects of coronavirus disease 2019 (COVID-19) on dermatology practice. We discuss the impact on practice volume and procedures and on the considerable increase in teledermatology use. We also describe the important roles that dermatologists have played in enhancing infection prevention and on the frontline. During the crisis, dermatologists have faced the challenge of a shortage of resources, such as personal protective equipment, in the health care system. In addition, they have been involved in managing cutaneous manifestations related to COVID-19 and occupational disease caused by personal protective equipment. Dermatologists have made a diligent effort to identify melanoma and to ensure the treatment of high-risk skin cancers. Safety guidelines have been suggested to minimize the potential risks associated with the systemic use of immunosuppressant agents and immunomodulators in patients with severe inflammatory skin disease during the pandemic. Finally, social distancing necessitated that dermatology conferences take place virtually and teaching via e-learning increased.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.